Protocol for the postoperative radiotherapy in N1 breast cancer patients (PORT-N1) trial, a prospective multicenter, randomized, controlled, non-inferiority trial of patients receiving breast-conserving surgery or mastectomy.
Tae-Hoon LeeJi Hyun ChangBum-Sup JangJae Sik KimTae Hyun KimWon ParkYong Bae KimSu Ssan KimWonshik HanHan-Byoel LeeKyung Hwan ShinPublished in: BMC cancer (2022)
This trial was registered at ClinicalTrials.gov (NCT05440149) on June 30, 2022.
Keyphrases
- phase iii
- phase ii
- study protocol
- double blind
- clinical trial
- open label
- placebo controlled
- randomized controlled trial
- minimally invasive
- early stage
- patients undergoing
- squamous cell carcinoma
- radiation therapy
- radiation induced
- locally advanced
- cross sectional
- coronary artery disease
- acute coronary syndrome
- neoadjuvant chemotherapy
- surgical site infection
- atrial fibrillation